Laparoscopy in pancreatic and hepatobiliary cancer

Surgical Oncology Clinics of North America

Volumn 10, Issue 3, 2001, Pages 531-555

  Burdiles, P ^a   Rossi, R L ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CANCER PALLIATIVE THERAPY; CANCER STAGING; COLORECTAL CARCINOMA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; ENDOSCOPIC SURGERY; HEPATOBILIARY SYSTEM CANCER; HUMAN; LAPAROSCOPIC SURGERY; LIVER CANCER; METASTASIS; MINIMALLY INVASIVE SURGERY; PANCREAS CANCER; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; SURGICAL TECHNIQUE;

EID: 0034826668     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30048-6     Document Type: Review

References (81)

1. Role of staging laparoscopy in the treatment of hepatic malignancies
2. Improved staging of liver tumors using laparoscopic intraoperative ultrasound
3. Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region
4. Organoscopy: Cystoscopy of the abdominal cavity
5. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy
6. Relationship between hospital volume and late survival after pancreaticoduodenectomy
7. Laparoscopic gastrojejunostomy in the palliation of pancreatic cancer. Reflections on the preliminary results
8. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy
9. Laparoscopic ultrasonography for hepatobiliary and pancreatic malignancies
10. Hepatic cryotherapy for liver tumors
11. Value of laparoscopy in the diagnosis and management of pancreatic carcinoma
12. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer
13. TNM staging and assessment of resectability of pancreatic cancer by laparoscopic ultrasonography
14. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass
15. Laparoscopic intra-arterial catheter implantation
16. Laparoscopic staging and peritoneal cytology
17. Standards for pancreatic resection in the 1990s
18. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer
19. Hepatocellular carcinoma: An analysis of 412 cases at a Western center
20. Laparoscopic ultrasound vs. triphasic computed tomography for detecting liver tumors
21. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer: I. Treatment by hepatic resection
22. Diagnosis and staging of pancreaticadenocarcinoma with dynamic computed tomography
23. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies
24. Thin section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms
25. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases
26. Laparoscopic resection of solid liver tumors
27. Preoperative imaging of liver metastases: Comparison of angiography, CT scan, and ultrasonography
28. Hepatic resection for noncolorectal, non-neuroendocrine metastases: A fifteen-year experience with ninety-six patients
29. Second look operation in managing carcinoma of the pancreas and periampullary region
30. Magnetic resonance imaging with magnetic resonance cholangiopancreatography accurately predicts resectability of pancreatic carcinoma
31. Peritoneoscopy and pancreatic biopsy in the diagnosis of the pancreatic disease
32. A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies
33. Liver resection for metastatic colorectal cancer: Assessing the risk of occult irresectable disease
34. Impact of laparoscopic staging in the treatment of pancreatic cancer
35. Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound
36. Laparoscopy with laparoscopic ultrasonography in the TNM staging of pancreatic carcinoma
37. Laparoscopic partial hepatectomy and left lateral segmentectomy
38. Preoperative evaluation of patients for liver resection
39. Comparisons of dynamic infusion and delayed computed tomography, intraoperative ultrasound, and palpation in the diagnosis of liver metastases
40. Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head
41. Pancreatic cancer: Cytologic study of peritoneal washings
42. Is prophylactic gastrojejunosomy indicated for unresectable periampullary cancer?
43. Pancreaticoduodenectomy: Does it have a role in the palliation of pancreatic cancer?
44. Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma
45. Implications of peritoneal cytology for pancreatic cancer management
46. Clinical and pathologic correlation in patients with periampullary tumors
47. Multidisciplinary considerations for patients with cancer of the pancreas or biliary tract
48. Prediction of resectability of pancreatic malignancy by computed tomography
49. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma
50. Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer
51. Diagnosis and staging of pancreatic neoplasms
52. Reoperation for pancreatic cancer
53. Experimental pancreatic tumor growth and spread after laparoscopy versus laparotomy in the rat
54. The efficacy of laparoscopic staging in patients with upper gastrointestinal tumors
55. Intraoperative quick immunoperoxidase staining: A useful adjunct to routine pathological diagnosis in pancreatic carcinoma
56. Laparoscopy and laparoscopic ultrasonography for staging pancreatic cancer: Critical appraisal
57. Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography
58. Experience with staging laparoscopy in pancreatic malignancy
59. Laparoscopic surgery for solid lesions
60. Laparoscopic gastro- and hepaticojejunostomy for palliation of pancreatic cancer. A case controlled study
61. Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?
62. Laparoscopy in the management of pancreatic cancer: Endoscopic cholecystojejunostomy for advanced disease
63. Surgical palliation for pancreatic cancer: The UCLA experience
64. Imaging and staging of biliopancreatic malignancy: Role of ultrasound
65. Re-exploration for periampullary carcinoma. Resectability, perioperative results, pathology, and long-term outcome
66. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990's
67. Importance of hospital volume in the overall management of pancreatic cancer
68. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal tumor study group protocol 6584
69. Diagnosis and staging of pancreatic neoplasms
70. Simultaneous hepatic resection with pancreatoduodenectomy for metastatic pancreatic head carcinoma: Does it improve survival?
71. Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors
72. Hepatic malignancies
73. Reoperative pancreaticoduodenectomy
74. Laparoscopic ultrasound enhances diagnostic laparoscopy in the staging of intra-abdominal neoplasms
75. Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: Correlation with surgical findings
76. Laparoscopy in the staging and planning of therapy for pancreatic cancer
77. Implications of peritoneal cytology for staging of early pancreatic cancer
78. Surgical palliation for pancreatic cancer: Developments during the past two decades
79. CT assessment of the inferior peripancreatic veins: Clinical significance
80. Microwave coagulonecrotic therapy for hepatocellular carcinoma
81. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Pathology, complications and outcomes